Alloy Therapeutics

Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics

BioSpace · 5 days ago

Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery

BioSpace · about 2 months ago

Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery

Business Wire · about 2 months ago

Staying private: Alloy Therapeutics raises $40m to fuel expansion

BioXconomy · 2 months ago

Alloy Therapeutics: $40 Million Series E At $1 Billion Valuation Raised To Scale AI-Driven Biotech Infrastructure

Pulse 2.0 · 2 months ago

Alloy Therapeutics Raises $40M in Series E Funding

FinSMEs · 2 months ago

Alloy Therapeutics Secures $40M To Accelerate AI Drug Development

Ventureburn · 2 months ago

Alloy Therapeutics Secures $40M To Accelerate AI Drug Development

Ventureburn · 2 months ago

Alloy Therapeutics Raises $40M Series E at $1B Valuation to Expand AI-Driven Drug Development Platform

citybiz · 2 months ago

Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure

Business Wire · 2 months ago

Boost for Cambridge as US company Alloy Therapeutics shows real Vigilance

Business Weekly · 3 months ago

Biogen to use Alloy Therapeutics’ Anticlastic ASO platform

BioWorld News · 3 months ago

Alloy Therapeutics Enters Into Multi-Target Collaboration And License Agreement With Biogen For Use Of Alloy’S Anticlastic™ Aso Platform

TradingView · 3 months ago

Alloy Therapeutics Enters into Multi-Target Collaboration and License Agreement with Biogen for Use of Alloy’s AntiClastic™ ASO Platform

Business Wire · 3 months ago

Alloy Therapeutics Appoints Alexander Titus, Ph.D., to Lead New Vigilance Division Focused on Biosecurity and Rapid Therapeutic Response

BioSpace · 3 months ago

Alloy Therapeutics Appoints Alexander Titus, Ph.D., to Lead New Vigilance Division

citybiz · 3 months ago

Alloy Therapeutics Appoints Alexander Titus to Lead New AI-Driven Vigilance Division

citybiz · 3 months ago

Alloy Therapeutics Appoints Alexander Titus, Ph.D., to Lead New Vigilance Division Focused on Biosecurity and Rapid Therapeutic Response

Business Wire · 3 months ago

AbbVie, Alloy Therapeutics Ink Deal to Develop Next-Gen Antibody Platform

Yahoo Finance · 3 months ago

AbbVie (ABBV) Partners with Alloy Therapeutics for Advanced Anti

GuruFocus · 3 months ago